Cigarette smoking in methadone maintained patients: an up-to-date review.

Ali Zirakzadeh, Charles Shuman, Erinn Stauter, J Taylor Hays, Jon O Ebbert
{"title":"Cigarette smoking in methadone maintained patients: an up-to-date review.","authors":"Ali Zirakzadeh,&nbsp;Charles Shuman,&nbsp;Erinn Stauter,&nbsp;J Taylor Hays,&nbsp;Jon O Ebbert","doi":"10.2174/1874473711306010009","DOIUrl":null,"url":null,"abstract":"<p><p>Tobacco dependence is the leading cause of preventable death and disability in the United States. While smoking prevalence among U.S. adults is 19.3%, the prevalence of smoking among methadone-maintained patients ranges between 73.5% and 94%. Most methadone-maintained smokers (76%-80%) desire to quit smoking; however only a minority of these smokers receive cessation treatment or referrals for smoking cessation intervention. Smoking cessation treatment in methadone-maintained patients has generally been successful in reducing the daily number of cigarettes smoked. Unfortunately, sustained cessation rates using nicotine replacement therapy and behavioral interventions have generally been low (0%-11%). Poor cessation outcomes may be partially explained by pharmacodynamic interactions between nicotine and methadone leading to increased reinforcement of smoking behavior. Further research is needed to improve smoking cessation rates in methadone-maintained patients. </p>","PeriodicalId":72730,"journal":{"name":"Current drug abuse reviews","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874473711306010009","citationCount":"44","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug abuse reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874473711306010009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 44

Abstract

Tobacco dependence is the leading cause of preventable death and disability in the United States. While smoking prevalence among U.S. adults is 19.3%, the prevalence of smoking among methadone-maintained patients ranges between 73.5% and 94%. Most methadone-maintained smokers (76%-80%) desire to quit smoking; however only a minority of these smokers receive cessation treatment or referrals for smoking cessation intervention. Smoking cessation treatment in methadone-maintained patients has generally been successful in reducing the daily number of cigarettes smoked. Unfortunately, sustained cessation rates using nicotine replacement therapy and behavioral interventions have generally been low (0%-11%). Poor cessation outcomes may be partially explained by pharmacodynamic interactions between nicotine and methadone leading to increased reinforcement of smoking behavior. Further research is needed to improve smoking cessation rates in methadone-maintained patients.

美沙酮维持患者吸烟:最新综述。
在美国,烟草依赖是导致可预防的死亡和残疾的主要原因。美国成年人的吸烟率为19.3%,而美沙酮维持患者的吸烟率为73.5%至94%。大多数美沙酮维持吸烟者(76%-80%)希望戒烟;然而,这些吸烟者中只有少数人接受戒烟治疗或转诊进行戒烟干预。在维持美沙酮的患者中,戒烟治疗通常在减少每日吸烟数量方面是成功的。不幸的是,使用尼古丁替代疗法和行为干预的持续戒烟率通常很低(0%-11%)。戒烟效果不佳的部分原因可能是尼古丁和美沙酮之间的药效学相互作用导致吸烟行为的增强。需要进一步的研究来提高美沙酮维持患者的戒烟率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信